Competent Cells

Global Market Trajectory & Analytics

MCP11217

EXECUTIVE ENGAGEMENTS

POOL

2522
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

454
Interactions with Platform & by Email

PARTICIPANTS

76
Unique # Participated

VALIDATIONS

22
Responses Validated*

COMPANIES

46
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

100

PAGES

176

EDITION

7

PRICE

USD 4950

CODE

MCP11217


COMPETITIVE METRICS

COMPANY

D S N T

% *

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Codex DNA, Inc.

Fisher Scientific Company, L.L.C.

GenScript Biotech Corporation

Illumina, Inc.

Meridian Bioscience, Inc.

New England Biolabs, Inc.

OriGene Technologies, Inc.

Promega Corporation

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Competent Cells estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 7-year period.
The Competent Cells market in the U.S. is estimated at US$490.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$519.3 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.2% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

SELECT PLAYERS

Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; GenScript Biotech Corporation; Illumina, Inc.; Merck KgaA; New England Biolabs, Inc.; OriGene Technologies, Inc.; Promega Corporation; Qiagen NV; Takara Bio, Inc.; Thermo Fisher Scientific, Inc.; Zymo Research Corporation

SEGMENTS

» Application (Cloning, Protein Expression, Other Applications) » End-Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)) » Type (Chemically Competent Cells, Electrocompetent Cells)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Clean-Label Starch Innovations
Chemically Competent Cells Segment Dominate in North America
Drivers & Restrains Summarized for Competent Cells Market
Cloning is Expected to Take the Largest Share of Competent Cells Market
Competent Cells Growth Outlook
Competent Cells Application Trends
Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market
Leading Players in competent cells market
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advancements in Molecular Cloning Drives Competent Cell Market
Drivers and Restraints Summarised
SGI-DNA Inc has Launched Vmax™ Express Chemically Competent Cells .
Increasing Research on Cloning Demands Competent Cells Requirement
Increasing Intensity of Research and Technological Advancements Drives Market
Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells
Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells
Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins
Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells
Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells
Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth
Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods
Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method
Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells
Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth
Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery
Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030
Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Competent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Chemically Competent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Chemically Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Electrocompetent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Electrocompetent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Protein Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Protein Expression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
USA Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
USA Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Canada Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Canada Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Japan Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Japan Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
China Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
China Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Competent Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Europe Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Europe Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
France Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
France Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Germany Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Germany Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Italy Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Italy Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
UK Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
UK Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2020 & 2027
Rest of World Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2020 & 2027
Rest of World Current & Future Analysis for Competent Cells by End-Use - Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs) for the Years 2020 & 2027
Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com